Aptamer-based Biosensor Developed to Monitor MUC1 Released by Prostate Cancer Cells

被引:27
|
作者
Karpik, Agnieszka E. [1 ]
Crulhas, Bruno P. [2 ]
Rodrigues, Carolina B. [2 ]
Castro, Gustavo R. [2 ]
Pedrosa, Valber A. [2 ]
机构
[1] Inst Mat Sci & Engn, Fac Mech Engn, Lodz, Poland
[2] UNESP, Dept Chem & Biochem, Inst Biosci, Botucatu, SP, Brazil
基金
巴西圣保罗研究基金会;
关键词
Electrochemical detection; protein monitoring; cancer; biomarkers; aptamers; ELECTROCHEMICAL DETECTION; ENZYME-IMMUNOASSAY; PANCREATIC-CANCER; LIGHT-SCATTERING; TUMOR; ONCOPROTEIN; APTASENSOR; EXPRESSION; ANTIGEN; TRANSCRIPTION;
D O I
10.1002/elan.201700318
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
Electrochemical aptasensors can detect cancer biomarkers such as mucin 1 (MUC1) to provide point-of-care diagnosis that is low-cost, specific and sensitive. Herein, a DNA hairpin containing MUC1 aptamer was thiolated, conjugated with methylene blue (MB) redox tag, and immobilized on a gold electrode by self-assembly. The fabrication process was characterized by scanning electron microscopy, X-ray spectroscopy analysis and electrochemistry techniques. The results evidenced a stable and sensitivity sensor presenting wide linear detection range (0.65-110 ng/mL). Therefore, it was able to precisely detect MUC1 production patterns in normal (RWPE-1) and prostate cancer cells (LNCaP and PC3). The biosensor has ability to detect MUC1 in complex samples being an efficient and useful platform for cancer diagnosing in early stages and for physiological applications such as cancer treatment monitoring.
引用
收藏
页码:2246 / 2253
页数:8
相关论文
共 50 条
  • [41] Novel electrochemical aptamer biosensor based on an enzyme-gold nanoparticle dual label for the ultrasensitive detection of epithelial tumour marker MUC1
    Hu, Rong
    Wen, Wei
    Wang, Qingling
    Xiong, Huayu
    Zhang, Xiuhua
    Gu, Haoshuang
    Wang, Shengfu
    BIOSENSORS & BIOELECTRONICS, 2014, 53 : 384 - 389
  • [42] MUC1 expression in prostate cancer: is there a correlation with diseaserecurrence following radical prostatectomy?
    Dundee, P.
    Clouston, D.
    Joseph, B.
    Newell, B.
    Bolton, D.
    BJU INTERNATIONAL, 2009, 103 : 32 - 32
  • [43] MUC1 expression in human prostate cancer cell lines and primary tumors
    J C O'Connor
    J Julian
    S D Lim
    D D Carson
    Prostate Cancer and Prostatic Diseases, 2005, 8 : 36 - 44
  • [44] Expression of sialylated MUC1 in prostate cancer: Relationship to clinical stage and prognosis
    Arai, T
    Fujita, K
    Fujime, M
    Irimura, T
    INTERNATIONAL JOURNAL OF UROLOGY, 2005, 12 (07) : 654 - 661
  • [45] MUC1 expression in human prostate cancer cell lines and primary tumors
    O'Connor, JC
    Julian, J
    Lim, SD
    Carson, DD
    PROSTATE CANCER AND PROSTATIC DISEASES, 2005, 8 (01) : 36 - 44
  • [46] Aptamer-functionalized polydiacetylene liposomes act as a fluorescent sensor for sensitive detection of MUC1 and targeted imaging of cancer cells
    Wang, Dong-En
    Gao, Xiaohua
    You, Shangqi
    Chen, Meng
    Ren, Li
    Sun, Wujin
    Yang, Hui
    Xu, Huiyun
    SENSORS AND ACTUATORS B-CHEMICAL, 2020, 309
  • [47] Aptamer-based and DNAzyme-linked colorimetric detection of cancer cells
    Zhu, Xiaoli
    Cao, Ya
    Liang, Zhiqiang
    Li, Genxi
    PROTEIN & CELL, 2010, 1 (09) : 842 - 846
  • [48] Aptamer-based and DNAzyme-linked colorimetric detection of cancer cells
    Xiaoli Zhu
    Ya Cao
    Zhiqiang Liang
    Genxi Li
    Protein & Cell, 2010, 1 (09) : 842 - 846
  • [49] MUC1, MUC2, MUC4, MUC5AC and MUC6 expression in the progression of prostate cancer
    Cozzi, PJ
    Wang, J
    Delprado, W
    Perkins, AC
    Allen, BJ
    Russell, PJ
    Li, Y
    CLINICAL & EXPERIMENTAL METASTASIS, 2005, 22 (07) : 565 - 573
  • [50] MUC1* is a determinant of trastuzumab (Herceptin) resistance in breast cancer cells
    Fessler, Shawn P.
    Wotkowicz, Mark T.
    Mahanta, Sanjeev K.
    Bamdad, Cynthia
    BREAST CANCER RESEARCH AND TREATMENT, 2009, 118 (01) : 113 - 124